LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

Search

Codexis Inc

Fermé

SecteurSoins de santé

2.43 -1.22

Résumé

Variation du prix de l'action

24h

Actuel

Min

2.31

Max

2.46

Chiffres clés

By Trading Economics

Revenu

10M

-10M

Ventes

8.6M

21M

BPA

-0.13

Marge bénéficiaire

-48.35

Employés

188

EBITDA

3.8M

-9.9M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+163.16% upside

Dividendes

By Dow Jones

Prochains Résultats

7 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-7.8M

219M

Ouverture précédente

3.65

Clôture précédente

2.43

Sentiment de l'Actualité

By Acuity

68%

32%

121 / 382 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Codexis Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 mai 2025, 20:40 UTC

Acquisitions, Fusions, Rachats

FedEx Names CEO, Chairman for Planned Freight Spinoff

19 mai 2025, 23:48 UTC

Market Talk

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19 mai 2025, 23:43 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

19 mai 2025, 22:33 UTC

Market Talk

Uranium Buyers Could Accelerate Restocking -- Market Talk

19 mai 2025, 22:16 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19 mai 2025, 22:16 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Sell Stake for CNY4.15B

19 mai 2025, 22:15 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Sell Stake to China Resources Land

19 mai 2025, 22:15 UTC

Acquisitions, Fusions, Rachats

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19 mai 2025, 22:02 UTC

Résultats

Trip.com Group 1Q Rev $1.9B >TCOM

19 mai 2025, 22:02 UTC

Résultats

Trip.com Group 1Q Adj EPS 82c >TCOM

19 mai 2025, 22:02 UTC

Résultats

Trip.com Group 1Q EPS 84c >TCOM

19 mai 2025, 21:58 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

19 mai 2025, 21:58 UTC

Market Talk

Global Equities Roundup: Market Talk

19 mai 2025, 21:58 UTC

Market Talk

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19 mai 2025, 21:50 UTC

Résultats

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19 mai 2025, 20:21 UTC

Acquisitions, Fusions, Rachats

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19 mai 2025, 20:20 UTC

Actualités

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19 mai 2025, 20:15 UTC

Acquisitions, Fusions, Rachats

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19 mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

19 mai 2025, 19:59 UTC

Actualités

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19 mai 2025, 19:58 UTC

Market Talk

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19 mai 2025, 19:52 UTC

Market Talk

Imports Accelerate at Southern California Ports -- Market Talk

19 mai 2025, 19:16 UTC

Market Talk

Oil Futures Edge Up After Shaky Start -- Market Talk

19 mai 2025, 19:00 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Sanmina Shares Fall After Deal to Buy AMD's Newly Acquired Manufacturing Company

19 mai 2025, 18:46 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

Comparaison

Variation de prix

Codexis Inc prévision

Objectif de Prix

By TipRanks

163.16% hausse

Prévisions sur 12 Mois

Moyen 6.5 USD  163.16%

Haut 11 USD

Bas 3 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

4

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

2.25 / 2.53Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

121 / 382Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.